Compare Revvity Inc (RVTY) vs Roundhill S&P 500 0DTE Covered Call Strategy ETF (XDTE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Revvity Inc vs Roundhill S&P 500 0DTE Covered Call Strategy ETF — how do they compare? Revvity Inc trades at $110.1 (market cap $11.87B), while Roundhill S&P 500 0DTE Covered Call Strategy ETF trades at $38.69. The key difference: Revvity Inc pays a 0.26% dividend while Roundhill S&P 500 0DTE Covered Call Strategy ETF pays none, and Revvity Inc is trading nearer its 52-week high, Roundhill S&P 500 0DTE Covered Call Strategy ETF nearer its low. Which is the better fit depends on your goals.
| RVTY | XDTE | |
|---|---|---|
Market Cap | $11.87B | — |
Sector | Technology | Income / Options Overlay |
52-Week High | $117.75 | $44.76 |
52-Week Low | $82.26 | $36.00 |
Enterprise Value | $14.36B | — |
Dividend Yield | 0.26% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RVTY trades at $106.44, down 3.37% today, with a bullish technical outlook despite near-term weakness. The company maintains stable revenue around $2.9B with consistent earnings beats, though valuation multiples appear elevated with a P/E of 51. Recent AI product launches and FDA clearances demonstrate innovation in life sciences and diagnostics. Analyst consensus remains positive with a $111.43 price target and no sell ratings among 29 covering firms.
The stock presents a growth opportunity with strong analyst support and technological innovation, but faces risks from margin pressure and China market exposure. Current levels near support at $105 offer potential entry, though the high P/E requires sustained earnings growth to justify valuation. Upcoming Q2 earnings on August 4, 2026 will be critical for near-term direction.
XDTE trades at $38.44, down 0.1% on the day, with technical indicators showing a bearish trend. The ETF generates frequent dividend payouts but faces scrutiny over sustainability. Recent news highlights concerns about yield calculations and NAV erosion despite high distribution frequency.
The outlook remains cautious due to structural risks in the covered call strategy and declining NAV. Investors face trade-offs between high income potential and capital depreciation risks in volatile markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →About Roundhill S&P 500 0DTE Covered Call Strategy ETF
XDTE is an actively managed ETF that utilizes a synthetic covered call strategy on the S&P 500 Index using zero-days-to-expiration (0DTE) options. It seeks to provide high weekly income and overnight exposure to the index while mitigating some volatility through daily option premium harvesting.
Read more on XDTE →
